Skip to main content
. 2019 Oct 23;18(6):4733–4739. doi: 10.3892/etm.2019.8123

Table I.

AST, ALT and TG levels in each group.

Group ALT (U/l) TG (mmol/l) AST (U/l)
C 19.92±4.98 0.74±0.03 59.26±6.23
M 43.59±0.61a 1.95±0.06a 65.38±2.24a
T 36.66±1.12b 1.62±0.36b 52.94±2.92b
G 34.56±4.05b 1.52±0.04b 47.62±4.56b
N 35.42±3.53b 1.47±0.04b 49.62±1.22b
L 23.38±4.91b 0.90±0.14b 37.61±3.37b

Data are reported as mean ± SD, n=10.

a

P<0.01 vs. C group

b

P<0.01 vs. M group. ALT, alanine aminotransferase; TG, triglycerides; AST, aspartate transaminase. C, control group; M, ALD group; T, Golden Bifid treatment group; G, Glutamine treatment group; N, Medilac-S® treatment group; L, Golden Bifido and glutamine treatment group.